SEC Form 4 · accession 0001104659-15-023587
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Diane G. Gerst
Officer — Corp. SVP of Quality Assurance
Period of report
Mar 26, 2015
Accepted (ET)
Mar 30, 2015 · 6:06 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 26, 2015 | A | 6,688 | $0.00 | A | 19,496 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $14.95 | Mar 26, 2015 | A | 20,028 | D | — | Mar 26, 2025 | Common Stock | 20,028 | 20,028 | D |
Explanation of responses
- F1The reported securities are represented by deferred stock units which vest in four equal annual installments beginning on March 26, 2016.
- F2Shares subject to the option vest in four equal annual installments beginning on March 26, 2016.